Safety and effectiveness of recombinant factor XIII-A<sub>2</sub> in congenital factor XIII deficiency: Real-world evidence.

Safety and effectiveness of recombinant factor XIII-A₂ in congenital factor XIII deficiency: Real-world evidence.

Poulsen, Lone Hvitfeldt; Kerlin, Bryce A; Castaman, Giancarlo; Molinari, Angelo Claudio; Menegatti, Marzia; Nugent, Diane; Dey, Sohan; Garly, May-Lill; Carcao, Manuel.

Afiliación

Poulsen LH; The Haemophilia Center Department of Hematology Aarhus University Hospital Aarhus Denmark.
Kerlin BA; The Ohio State University College of Medicine Nationwide Children's Hospital Columbus Ohio USA.
Castaman G; Center for Bleeding Disorders and Coagulation Department of Oncology Careggi University Hospital Firenze Italy.
Molinari AC; Regional Reference Center for Hemorrhagic Diseases Giannina Gaslini Children's Hospital Genoa Italy.
Menegatti M; IRCCS Fondazione Ca' Granda Ospedale Maggiore Policlinico Angelo Bianchi Bonomi Hemophilia and Thrombosis Center Milan Italy.
Nugent D; Children's Hospital of Orange County University of California at Irvine, and Center for Inherited Blood Disorders Orange California USA.
Dey S; Novo Nordisk Service Centre India Private Ltd Bangalore India.
Garly ML; Novo Nordisk A/S Søborg Denmark.
Carcao M; Division of Haematology/Oncology Department of Paediatrics and Child Health Evaluative Sciences Research Institute, Hospital for Sick Children University of Toronto Toronto Ontario Canada.